Relmada Therapeutics
Price & Volume
Stats
See more52W Range | $0.28-$7.22 |
Market Cap | $8.9M |
Shares Short | 838,002 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.86 |
News
See moreYahoo Finance • last year
Positive Signs As Multiple Insiders Buy Relmada Therapeutics Stock
Yahoo Finance • 2 years ago
Bragar Eagel & Squire, P.C. Is Investigating Shift4, Waldencast, Relmada, and DoubleVerify and Encourages Investors to Contact the Firm
About
CEO | Dr. Sergio Traversa M.B.A., Pharm.D. |
Address | 2222 Ponce de Leon Boulevard, Coral Gables, FL, United States, 33134 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 20 |
